-
平臺編號：bio-83319
-
國際編號：ATCC 96284
-
拉丁屬名： Aspergillus fischeri var. brasiliensis
-
規(guī)格：freeze-dried
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
AB 1826M-35
Aspergillus fischeri var. brasiliensis Karwowski et al., anamorph 拉丁名
(ATCC® 96284™) 統(tǒng)一編號
Strain Designations 菌種別名 AB 1826M-35 [NRRL 18896]
Application 用途 produces 5-N-acetylardeemin
Biosafety Level 生物安全等級 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 freeze-dried
Type Strain 模式菌株 no
Preceptrol® no
Medium 培養(yǎng)基 ATCC® Medium 325: Malt extract agar (Blakeslee's formula)
Growth Conditions 生長條件
Temperature 培養(yǎng)溫度 : 37.0°C
Sequenced Data No DNA sequencing was performed in house on this product.
Name of Depositor 寄存人 Abbott Labs.
Special Collection NCRR Contract
Chain of Custody 來源國家 ATCC <<--Abbott Labs.<<--P. Humphrey
Isolation 分離源 soil, Brazil
References 參考文獻(xiàn) Kadam SK, et al. Multiple drug resistance-attenuating compounds. US Patent 5,284,947 dated Feb 8 1994
Karwowski JP, et al. 5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. I. Taxonomy and fermentation of the producing organism and biological activity. J. Antibiot. 46: 374-379, 1993. PubMed: 8478255
Hochlowski JE, et al. 5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. II. Isolation and elucidation of the structure of 5-N-acetylardeemin and two congeners. J. Antibiot. 46: 380-386, 1993. PubMed: 8478256
